CPT® Code 86789

The CPT® Code 86789 refers to the laboratory test for detecting antibodies specific to the West Nile virus. This test is crucial for diagnosing infections caused by the West Nile virus, which can lead to serious neurological diseases. The antibody test specifically measures the presence of immunoglobulin M (IgM) antibodies, which are produced by the immune system in response to the virus. The testing process typically involves collecting blood serum or cerebrospinal fluid (CSF) samples from patients who exhibit symptoms of West Nile virus infection. It is important that these samples are collected within a specific timeframe, ideally between 8 to 21 days after the onset of symptoms, to ensure accurate results. The testing protocol often includes an initial serum sample followed by a second sample taken at least two weeks later, allowing for the assessment of changes in antibody levels during the acute and convalescent phases of the infection. The most reliable method for confirming the presence of IgM antibodies is through the IgM antibody capture enzyme-linked immunosorbent assay (MAC-ELISA), particularly when analyzing CSF samples. This is because IgM antibodies do not cross the intact blood-brain barrier; thus, their detection in CSF is a strong indicator of a central nervous system infection. Additionally, plaque-reduction neutralizing tests can be performed on paired serum or CSF samples collected at least two weeks apart, with a four-fold increase in antibody titer serving as confirmation of West Nile virus infection.